80. Jahresversammlung 2009
der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde,
Kopf- und Hals-Chirurgie e.V.

Samstag, 23. Mai 2009

Persönlichen Planer anschauen        Kongressplaner drucken			Persönl. Kongressplaner
02.00–05.00 p.m.— Konferenzsaal 1			Teilnahme planen	Outlook Export: Outlook Vers. wählen
				2007	2003+älter
		INTERNATIONAL FORUM
		Oncology 3
Chairmen:		A. Weber, Essen (Germany); A. Gerstner, Bonn (Germany)
2.00–2.10 p.m.	450.	Invited Lecture 11 The value of transmandibular approach to total maxillectomy in the management T3–T4 carcinoma of the maxillary sinus R. Tiwari, Bangalore (India)
Free Lectures
2.10–3.30 p.m.	451.	Identification of differentially expressed genes in metastatic and nonmetastatic head and neck cancer C. Cordes, C. Werner, M. Hoffmann, P. Ambrosch et al., Kiel (Germany)
	452.	Results of the ex-vivo testing of combinatory effects of cisplatin and cetuximab on head and neck squamous cell carcinoma G. Wichmann, J. Termühlen, C. Mozet, A. Dietz et al., Leipzig (Germany)
	453.	Significant detection of mutagenic effects on primary human oropharyngeal epithelial cells using the micronucleus assay J. Brus, L. Keller, A. Reiche, A. Dietz et al., Leipzig (Germany)
	454.	Antagonists of the Hedgehog-Signaling-Pathway enhance the cytotoxicity of Cisplatin and Docetaxel in head and neck squamous cell carcinomas (HNSCC) C. Mozet, G. Wichmann, L. Tzagkaroulaki, A. Dietz et al., Leipzig (Germany)
	455.	Spheroids generated from head and neck cancer sell lines possess cancer stem-like cells charcteristics C. Chen, A. M. Kaufmann, M. Hummel, T. K. Hoffmann et al., Berlin/Essen (Germany)
	456.	HBD-1 gene expression and peptide localization in oral cancer and salivary gland tumors Annette Pantelis, M. Wenghoefer, W. Götz, S. Jepsen et al., Bonn (Germany)
	457.	Phenotype-assisted transcriptome analysis identifies FOXM1 down-stream from Ras-MKK3-p38 to regulate in-vitro cellular invasion C. Simon, A. Behren, S. Muehlen, P. Huber et al., Heidelberg/Boston (USA)
	458.	Role of nk cell overexpression of chemokine receptors and transcription factors in treated, relapse-free patients with head and neck squamous cell carcinomas A. Böttcher, J. Ostwald, S. Dommerich, B. Kramp et al., Rostock (Germany)
3.30–5.00 p.m.	459.	Round Table Discussion 9 Current developments in adjuvant treatment of head and neck cancer Moderator: A. Dietz, Leipzig (Germany) Panelists: V. Budach, Duesseldorf (Germany) U. Keilholz, Berlin (Germany) R. Knecht, Hamburg (Germany) Barbara Wollenberg, Luebeck (Germany)